C07K 2317/55
Fab or fab'
Official title: Fab or Fab'
C07K2317/55 (Fab or fab') appears on 4,445 US grants and 8,030 published applications in this corpus.
Search patents in C07K- Granted patents
- 4,445
- Published applications
- 8,030
- Assignees
- 1,951
- Inventors
- 11,356
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 6 | 0 |
| 1997 | 18 | 0 |
| 1998 | 32 | 0 |
| 1999 | 31 | 0 |
| 2000 | 33 | 0 |
| 2001 | 21 | 10 |
| 2002 | 23 | 38 |
| 2003 | 18 | 80 |
| 2004 | 12 | 88 |
| 2005 | 26 | 110 |
| 2006 | 38 | 138 |
| 2007 | 35 | 135 |
| 2008 | 48 | 120 |
| 2009 | 87 | 190 |
| 2010 | 97 | 209 |
| 2011 | 108 | 229 |
| 2012 | 146 | 252 |
| 2013 | 146 | 276 |
| 2014 | 177 | 344 |
| 2015 | 220 | 366 |
| 2016 | 239 | 483 |
| 2017 | 267 | 467 |
| 2018 | 270 | 471 |
| 2019 | 288 | 496 |
| 2020 | 318 | 530 |
| 2021 | 333 | 568 |
| 2022 | 282 | 540 |
| 2023 | 289 | 521 |
| 2024 | 330 | 555 |
| 2025 | 313 | 475 |
| 2026 | 185 | 339 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Antibodies against human TSLP and use thereof6 Oct 2026US 12,753,227 B2Beijing Wisdomab Biotechnology Co., Ltd
- Bifunctional molecules for lysosomal targeting and related compositions and methods6 Oct 2026US 12,753,239 B2The Board of Trustees of the Leland Stanford Junior University
- Tau-binding antibodies29 Sep 2026US 12,747,288 B2Ucb Biopharma Srl
- Anti-CCR8 antibodies for treating cancer29 Sep 2026US 12,747,296 B2Bristol-Myers Squibb Company
- Muscle-targeting complexes and uses thereof22 Sep 2026US 12,742,007 B2Dyne Therapeutics, Inc.
- Cd3 binding molecules8 Oct 2026US 2026/0308254 A1Merus N.V.
- A proimmunotoxin therapeutic nanoplatform against cancer8 Oct 2026US 2026/0308268 A1The Regents of the University of California
- Dual transporters and methods of use8 Oct 2026US 2026/0308269 A1Denali Therapeutics Inc.
- Engineered Antibodies and Uses Thereof8 Oct 2026US 2026/0308277 A1Invitrogen Bioservices India Private Limited
- Bispecific antigen binding molecule and use thereof1 Oct 2026US 2026/0297194 A1Shanghai Qilu Pharmaceutical Research and Development Centre Ltd.
Most cited
By later US patents
- Immunoglobulin variants1,380US 5,821,337 AGenentech, Inc. · 1998
- Production of chimeric antibodies - a combinatorial approach1,367US 5,565,332 ACambridge Antibody Technology Limited · 1996
- Humanized antibodies and methods for making them1,003US 6,054,297 AGenentech, Inc. · 2000
- Method for making humanized antibodies943US 6,407,213 B1Genentech, Inc. · 2002
- Methods for producing members of specific binding pairs893US 5,969,108 ACambridge Antibody Technology Limited · 1999